Portal de Periódicos da CAPES

In reference to Prescribing Practices and Barriers of Biologics for Chronic Rhinosinusitis Amongst Otolaryngologists

2024; Wiley; Linguagem: Inglês

10.1002/lary.31681

1531-4995

Diego M. Conti, Eduardo J. Correa, Javier Gómez‐Hervás, Merino Gálvez E,

Sinusitis and nasal conditions

The LaryngoscopeEarly View Letter to the Editor In reference to Prescribing Practices and Barriers of Biologics for Chronic Rhinosinusitis Amongst Otolaryngologists Diego M. Conti MD, Corresponding Author Diego M. Conti MD [email protected] orcid.org/0000-0002-8896-495X Escuela de Doctorado UAM, Centro de Estudios de Posgrado, Universidad Autónoma de Madrid, Madrid, Spain Allergy and Clinical Immunology Research Unit, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium Send correspondence to Diego M. Conti, Calle Francisco Tomás y Valiente, n° 2, Ciudad Universitaria de Cantoblanco, 28049 Madrid, Spain. Email: [email protected]Search for more papers by this authorEduardo J. Correa MD, Eduardo J. Correa MD orcid.org/0000-0002-6141-5360 Otolaryngology Department, Hospital Comarcal de la Línea de La Concepción, Cádiz, SpainSearch for more papers by this authorJavier Gómez-Hervás PhD, Javier Gómez-Hervás PhD orcid.org/0000-0002-3859-1374 Universidad Católica San Antonio de Murcia (San Antonio Catholic University of Murcia), Guadalupe, SpainSearch for more papers by this authorEsteban Merino-Galvez PhD, Esteban Merino-Galvez PhD orcid.org/0000-0003-3671-7794 Hospital Universitario Rafael Méndez [Rafael Mendez University Hospital], Murcia, SpainSearch for more papers by this author Diego M. Conti MD, Corresponding Author Diego M. Conti MD [email protected] orcid.org/0000-0002-8896-495X Escuela de Doctorado UAM, Centro de Estudios de Posgrado, Universidad Autónoma de Madrid, Madrid, Spain Allergy and Clinical Immunology Research Unit, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium Send correspondence to Diego M. Conti, Calle Francisco Tomás y Valiente, n° 2, Ciudad Universitaria de Cantoblanco, 28049 Madrid, Spain. Email: [email protected]Search for more papers by this authorEduardo J. Correa MD, Eduardo J. Correa MD orcid.org/0000-0002-6141-5360 Otolaryngology Department, Hospital Comarcal de la Línea de La Concepción, Cádiz, SpainSearch for more papers by this authorJavier Gómez-Hervás PhD, Javier Gómez-Hervás PhD orcid.org/0000-0002-3859-1374 Universidad Católica San Antonio de Murcia (San Antonio Catholic University of Murcia), Guadalupe, SpainSearch for more papers by this authorEsteban Merino-Galvez PhD, Esteban Merino-Galvez PhD orcid.org/0000-0003-3671-7794 Hospital Universitario Rafael Méndez [Rafael Mendez University Hospital], Murcia, SpainSearch for more papers by this author First published: 07 August 2024 https://doi.org/10.1002/lary.31681 Editor's Note: This Manuscript was accepted for publication on May 23, 2024. D.M.C. serves as Academic Manager at the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) and as Review Editor at Frontiers in Allergy, Rhinology Section. All other author have no conflicts of interest related to this initiative. The authors have no funding, financial relationships, or conflicts of interest to disclose. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. BIBLIOGRAPHY 1Bell CM, Thamboo AV, Monteiro E, Yip J. Prescribing practices and barriers of biologics for chronic rhinosinusitis amongst otolaryngologists. Laryngoscope. 2024; 134: 3493-3498. https://doi.org/10.1002/lary.31370. 10.1002/lary.31370 CASPubMedGoogle Scholar 2Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000; 356(9248): 2144-2148. https://doi.org/10.1016/s0140-6736(00)03496-6. 10.1016/S0140-6736(00)03496-6 CASPubMedWeb of Science®Google Scholar 3Striz I, Golebski K, Strizova Z, et al. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. Clin Sci. 2023; 137(9): 727-753. https://doi.org/10.1042/CS20190281. 10.1042/CS20190281 CASPubMedWeb of Science®Google Scholar 4Hellings PW, Fokkens WJ, Orlandi R, et al. The EUFOREA pocket guide for chronic rhinosinusitis. Rhinology. 2023; 61(1): 85-89. https://doi.org/10.4193/Rhin22.344. 10.4193/Rhin22.344 CASPubMedWeb of Science®Google Scholar 5Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019; 74(12): 2312-2319. https://doi.org/10.1111/all.13875. 10.1111/all.13875 PubMedWeb of Science®Google Scholar 6Hellings PW, Alobid I, Anselmo-Lima WT, et al. EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care. Allergy. 2023; 79: 1123-1133. https://doi.org/10.1111/all.15982. 10.1111/all.15982 PubMedGoogle Scholar 7Fokkens WJ, De Corso E, Backer V, et al. EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. Rhinology. 2024; 62: 287-298. https://doi.org/10.4193/Rhin23.415. 10.4193/Rhin23.415 CASPubMedGoogle Scholar 8 Sanofi Campus. N-Pass Handbook 2022. Accessed May 17, 2024. https://www.campus.sanofi/sa/science/nasal-polyps/cutting-edge-science/2022/ar/n-pass-handbook. Google Scholar 9 EUFOREA webpage. European Biologics Training Course 2024. Accessed May 17, 2024. https://www.euforea.eu/index.php/events/european-biologics-training-course-2024. Google Scholar 10Theeling T, Djouder C, Laurens H, et al. Nasal polyp syndrome: a patient-centred term for CRSwNP by EUFOREA. Front Allergy. 2024; 5:1372919. https://doi.org/10.3389/falgy.2024.1372919. 10.3389/falgy.2024.1372919 PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation